{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:22:20Z","timestamp":1769577740269,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00101-022-01221-9","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:06:57Z","timestamp":1669907217000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thrombotische Mikroangiopathien in der operativen Intensivmedizin unter besonderer Ber\u00fccksichtigung des atypischen h\u00e4molytisch-ur\u00e4mischen Syndroms","Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome"],"prefix":"10.1007","volume":"72","author":[{"given":"Sebastian","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Kamla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Sch\u00f6nermarck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Wassilowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"1221_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","volume":"152","author":"E Azoulay","year":"2017","unstructured":"Azoulay\u00a0E, Knoebl\u00a0P, Garnacho-Montero\u00a0J et al (2017) Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome. Chest 152:424\u2013434","journal-title":"Chest"},{"key":"1221_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2215\/CJN.00620117","volume":"13","author":"V Brocklebank","year":"2018","unstructured":"Brocklebank\u00a0V, Wood\u00a0KM, Kavanagh\u00a0D (2018) Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol 13:300\u2013317","journal-title":"Clin J Am Soc Nephrol"},{"key":"1221_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","volume":"35","author":"JM Campistol","year":"2015","unstructured":"Campistol\u00a0JM, Arias\u00a0M, Ariceta\u00a0G et\u00a0al (2015) An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 35:421\u2013447","journal-title":"Nefrologia"},{"key":"1221_CR4","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1182\/blood.2020009280","volume":"137","author":"F Fakhouri","year":"2021","unstructured":"Fakhouri\u00a0F, Fila\u00a0M, Hummel\u00a0A et al (2021) Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a\u00a0prospective multicenter study. Blood 137:2438\u20132449","journal-title":"Blood"},{"key":"1221_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri\u00a0F, Zuber\u00a0J, Fremeaux-Bacchi\u00a0V et al (2017) Haemolytic uraemic syndrome. Lancet 390:681\u2013696","journal-title":"Lancet"},{"key":"1221_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi\u00a0V, Fakhouri\u00a0F, Garnier\u00a0A et al (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a\u00a0nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562","journal-title":"Clin J Am Soc Nephrol"},{"key":"1221_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11560-021-00487-1","volume":"16","author":"A G\u00e4ckler","year":"2021","unstructured":"G\u00e4ckler\u00a0A, Witzke\u00a0O (2021) Thrombotische Mikroangiopathie. Nephrologe 16:113\u2013123","journal-title":"Nephrologe"},{"key":"1221_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George\u00a0JN, Nester\u00a0CM (2014) Syndromes of thrombotic microangiopathy. N\u00a0Engl J Med 371:654\u2013666","journal-title":"N Engl J Med"},{"key":"1221_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","volume":"91","author":"TH Goodship","year":"2017","unstructured":"Goodship\u00a0TH, Cook\u00a0HT, Fakhouri\u00a0F et\u00a0al (2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a\u00a0\u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int 91:539\u2013551","journal-title":"Kidney Int"},{"issue":"9","key":"1221_CR10","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.3390\/jcm9092900","volume":"9","author":"M Grigorescu","year":"2020","unstructured":"Grigorescu\u00a0M, Kamla\u00a0CE, Wassilowsky\u00a0D et\u00a0al (2020) Severe acute kidney injury in cardiovascular surgery: thrombotic microangiopathy as a\u00a0differential diagnosis to ischemia reperfusion injury. A retrospective study. J\u00a0Clin Med 9(9):2900. https:\/\/doi.org\/10.3390\/jcm9092900","journal-title":"J Clin Med"},{"key":"1221_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11560-019-0320-4","volume":"14","author":"H Haller","year":"2019","unstructured":"Haller\u00a0H (2019) Thrombotische Mikroangiopathie und Niere. Nephrologe 14:100\u2013107","journal-title":"Nephrologe"},{"key":"1221_CR12","first-page":"3","volume-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2021","author":"St\u00e4ndige Impfkommission","year":"2021","unstructured":"St\u00e4ndige Impfkommission (2021) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2021, S 3\u201363"},{"key":"1221_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/icvts\/ivab231","volume":"34","author":"CE Kamla","year":"2022","unstructured":"Kamla\u00a0CE, Grigorescu-Vlass\u00a0M, Wassilowsky\u00a0D et al (2022) Thrombotic microangiopathy following aortic surgery with hypothermic circulatory arrest: a\u00a0single-centre experience of an underestimated cause of acute renal failure. Interact CardioVasc Thorac Surg 34:258\u2013266","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"1221_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10157-017-1524-4","volume":"22","author":"H Kato","year":"2018","unstructured":"Kato\u00a0H, Nangaku\u00a0M, Okada\u00a0H et\u00a0al (2018) Controversies of the classification of TMA and the terminology of aHUS. Clin Exp Nephrol 22:979\u2013980","journal-title":"Clin Exp Nephrol"},{"key":"1221_CR15","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ekir.2021.07.004","volume":"6","author":"J Kaufeld","year":"2021","unstructured":"Kaufeld\u00a0J, Reinhardt\u00a0M, Schroder\u00a0C et al (2021) Atypical hemolytic and uremic syndrome triggered by infection with SARS-coV2. Kidney Int Rep 6:2709\u20132712","journal-title":"Kidney Int Rep"},{"issue":"11","key":"1221_CR16","first-page":"2","volume":"14","author":"J Laurence","year":"2016","unstructured":"Laurence\u00a0J, Haller\u00a0H, Mannucci\u00a0PM et\u00a0al (2016) Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clin Adv Hematol Oncol 14(11):2\u201315","journal-title":"Clin Adv Hematol Oncol"},{"key":"1221_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ekir.2021.04.036","volume":"6","author":"C Legendre","year":"2021","unstructured":"Legendre\u00a0C, Rebecca-Sberro-Soussan, Zuber\u00a0J (2021) Ravulizumab for the treatment of aHUS in adults: improving quality of life. Kidney Int Rep 6:1489\u20131491","journal-title":"Kidney Int Rep"},{"key":"1221_CR18","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre\u00a0CM, Licht\u00a0C, Muus\u00a0P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N\u00a0Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"1221_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/jth.13882","volume":"16","author":"A Li","year":"2018","unstructured":"Li\u00a0A, Khalighi\u00a0PR, Wu\u00a0Q et\u00a0al (2018) External validation of the PLASMIC score: a\u00a0clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J\u00a0Thromb Haemost 16:164\u2013169","journal-title":"J Thromb Haemost"},{"key":"1221_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccc.2019.11.004","volume":"36","author":"CL Manrique-Caballero","year":"2020","unstructured":"Manrique-Caballero\u00a0CL, Peerapornratana\u00a0S, Formeck\u00a0C et al (2020) Typical and atypical hemolytic uremic syndrome in the critically ill. Crit Care Clin 36:333\u2013356","journal-title":"Crit Care Clin"},{"key":"1221_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1182\/blood-2017-02-770214","volume":"130","author":"SA Merrill","year":"2017","unstructured":"Merrill\u00a0SA, Brittingham\u00a0ZD, Yuan\u00a0X et\u00a0al (2017) Eculizumab cessation in atypical hemolytic uremic syndrome. Blood 130:368\u2013372","journal-title":"Blood"},{"key":"1221_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","volume":"67","author":"CM Nester","year":"2015","unstructured":"Nester\u00a0CM, Barbour\u00a0T, de Cordoba\u00a0SR et\u00a0al (2015) Atypical aHUS: state of the art. Mol Immunol 67:31\u201342","journal-title":"Mol Immunol"},{"key":"1221_CR23","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris\u00a0M, Caprioli\u00a0J, Bresin\u00a0E et\u00a0al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"1221_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1744-9987.12763","volume":"23","author":"R Raina","year":"2019","unstructured":"Raina\u00a0R, Krishnappa\u00a0V, Blaha\u00a0T et al (2019) Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial 23:4\u201321","journal-title":"Ther Apher Dial"},{"key":"1221_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ckj\/sfz066","volume":"13","author":"U Schonermarck","year":"2020","unstructured":"Schonermarck\u00a0U, Ries\u00a0W, Schroppel\u00a0B et\u00a0al (2020) Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathy. Clin Kidney\u00a0J 13:208\u2013216","journal-title":"Clin Kidney J"},{"key":"1221_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully\u00a0M, Hunt\u00a0BJ, Benjamin\u00a0S et\u00a0al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158:323\u2013335","journal-title":"Br J Haematol"},{"key":"1221_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2018.07.006","volume":"461","author":"M Sridharan","year":"2018","unstructured":"Sridharan\u00a0M, Go\u00a0RS, Willrich\u00a0MAV (2018) Atypical hemolytic uremic syndrome: review of clinical presentation, diagnosis and management. J\u00a0Immunol Methods 461:15\u201322","journal-title":"J Immunol Methods"},{"key":"1221_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","volume":"148","author":"CM Taylor","year":"2010","unstructured":"Taylor\u00a0CM, Machin\u00a0S, Wigmore\u00a0SJ et\u00a0al (2010) Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 148:37\u201347","journal-title":"Br J Haematol"},{"key":"1221_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/CLEP.S245642","volume":"12","author":"K Yan","year":"2020","unstructured":"Yan\u00a0K, Desai\u00a0K, Gullapalli\u00a0L et\u00a0al (2020) Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review. Clin Epidemiol 12:295\u2013305","journal-title":"Clin Epidemiol"},{"key":"1221_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber\u00a0J, Fakhouri\u00a0F, Roumenina\u00a0LT et\u00a0al (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643\u2013657","journal-title":"Nat Rev Nephrol"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-022-01221-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T14:21:31Z","timestamp":1674138091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-022-01221-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1221"],"URL":"https:\/\/doi.org\/10.1007\/s00101-022-01221-9","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"17 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Albrecht, C.E.\u00a0Kamla, U.\u00a0Sch\u00f6nermarck und D.\u00a0Wassilowsky geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}